Qube Research & Technologies (QRT)’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
2,051,588
+633,439
| +45% | +$3.36M | 0.01% | 904 |
|
|
2025
Q1 | $12.6M | Buy |
1,418,149
+416,776
| +42% | +$3.7M | 0.01% | 743 |
|
|
2024
Q4 | $13.7M | Buy |
1,001,373
+492,749
| +97% | +$6.76M | 0.02% | 686 |
|
|
2024
Q3 | $13.9M | Buy |
508,624
+437,847
| +619% | +$12M | 0.02% | 616 |
|
|
2024
Q2 | $1.73M | Buy |
+70,777
| New | +$1.73M | ﹤0.01% | 1432 |
|
|
2024
Q1 | – | Sell |
-19,070
| Closed | -$365K | – | 4165 |
|
|
2023
Q4 | $365K | Sell |
19,070
-112,483
| -86% | -$2.15M | ﹤0.01% | 2122 |
|
|
2023
Q3 | $2.11M | Buy |
131,553
+113,000
| +609% | +$1.81M | 0.01% | 1098 |
|
|
2023
Q2 | $430K | Buy |
+18,553
| New | +$430K | ﹤0.01% | 1479 |
|
|
2022
Q3 | – | Sell |
-18,025
| Closed | -$328K | – | 2783 |
|
|
2022
Q2 | $328K | Buy |
+18,025
| New | +$328K | ﹤0.01% | 1544 |
|